@Hokuspokus77 ARDX: I am focusing on their FDA approved drug Ibsrela ($300-$500M peak sales) and bounce just like LPTX from oversold level Xphozah approval is basically a free call option for $4-$5 πŸ‘πŸΌ
3
3 Likes